A phase II study of tasisulam sodium (LY573636) as second-line treatment for patients with unresectable or metastatic melanoma. Background: Recurrence will occur in about 20% of all primary melanoma ...
A phase I/II study of topotecan and sorafenib in recurrent, platinum-resistant ovarian cancer: HOG GYN-111. Background: Postsurgical intraperitoneal (IP) platinum-based chemotherapy should be strongly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results